Novo Nordisk Canada Inc.
Registration:
2
of
3
(2023-12-08
to
2024-03-04)
Policies or Program
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.
- Support the establishment of a life sciences strategy in Canada
Policies or Program, Regulation
- Advocate for the establishment of public-private partnerships to support chronic disease prevention.
- Date Modified: